Morgan Stanley’s Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share VHAQ.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding VHAQ.WS
RCM
BFM
LA
KC
MI
KPF
M
PAMP
CH
SCM
Morgan Stanley's VHAQ.WS Position: Q3 2022 in Review
Morgan Stanley sold out of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) in Q3 2022, closing a stake of 1 share.
Morgan Stanley first reported a position in VHAQ.WS in Q1 2021 and held it in 6 quarters. The position peaked at $3K in Q1 2021. 31 funds tracked by Wall St. Rank hold VHAQ.WS as of Q3 2022.
- Morgan Stanley reported no remaining Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position as of Q3 2022 after selling out during the quarter.
- Morgan Stanley sold 1 Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share share in Q3 2022.
- Morgan Stanley first reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in Q1 2021 and held it in 6 quarters.
- Morgan Stanley's Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position peaked at $3K in Q1 2021.
- 31 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share as of Q3 2022.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.